Argos Therapeutics (FRA:77AA) Days Payable : 0.00 (As of Sep. 2018)

View and export this data going back to 2014. Start your Free Trial

What is Argos Therapeutics Days Payable?

Argos Therapeutics's average Accounts Payable for the three months ended in Sep. 2018 was €0.19 Mil. Argos Therapeutics's Cost of Goods Sold for the three months ended in Sep. 2018 was €0.00 Mil.

The historical rank and industry rank for Argos Therapeutics's Days Payable or its related term are showing as below:

FRA:77AA's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 148.145
* Ranked among companies with meaningful Days Payable only.

Argos Therapeutics's Days Payable stayed the same from Sep. 2017 (0.00) to Sep. 2018 (0.00). stayed the same

Argos Therapeutics Days Payable Historical Data

The historical data trend for Argos Therapeutics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Argos Therapeutics Days Payable Chart

Argos Therapeutics Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Days Payable

Get a 7-Day Free Trial

Argos Therapeutics Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
Days Payable	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Argos Therapeutics's Days Payable

For the Biotechnology subindustry, Argos Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Argos Therapeutics's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Argos Therapeutics's Days Payable distribution charts can be found below:

* The bar in red indicates where Argos Therapeutics's Days Payable falls into.

Argos Therapeutics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Argos Therapeutics's Days Payable for the fiscal year that ended in Dec. 2017 is calculated as

	Days Payable (A: Dec. 2017 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2016 )	+	Accounts Payable (A: Dec. 2017 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2017 )	*	Days in Period
=	( (5.097	+	0.82)	/	2 )	/	0	*	365
=	2.9585					/	0	*	365
=	N/A

Argos Therapeutics's Days Payable for the quarter that ended in Sep. 2018 is calculated as:

	Days Payable (Q: Sep. 2018 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2018 )	+	Accounts Payable (Q: Sep. 2018 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2018 )	*	Days in Period
=	( (0.098	+	0.28)	/	2 )	/	0	*	365 / 4
=	0.189					/	0	*	365 / 4
=	N/A

Argos Therapeutics Days Payable Related Terms

Thank you for viewing the detailed overview of Argos Therapeutics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Argos Therapeutics (FRA:77AA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Argos Therapeutics Inc (FRA:77AA) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

4233 Technology Drive, Durham, NC, USA, 27704

Website

http://www.argostherapeutics.com

Argos Therapeutics Inc is a biopharmaceutical company. It is engaged in the development and commercialization of immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis.

Argos Therapeutics (FRA:77AA) Headlines

No Headlines